Ausgabe 1/2024
Inhalt (16 Artikel)
“Navigating the evolving landscape of cancer treatment: a triad of progress”
Andreas Pircher
(Neo)adjuvant approaches: pavement on the road to cure—breast cancer
Eva Valentina Klocker
(Neo)adjuvant approaches in lung cancer—paving the road to a cure
Romana Wass, Maximilian Hochmair, David Lang, Andreas Horner, Bernd Lamprecht
Total neoadjuvant therapy for each locally advanced rectal cancer?
Gudrun Piringer
Management of oligometastatic prostate cancer
Marcin Miszczyk, Aleksander Slusarczyk, Fahad Quhal, Jakob Klemm, Akihiro Matsukawa, Mikołaj Przydacz, Piotr Bryniarski, Shahrokh F. Shariat, Paweł Rajwa
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
Stephan Brönimann, Nirmish Singla, Stephan M Korn, Nicolai A Huebner, Shahrokh F Shariat
Metastasis-directed therapy: new standard or too early to change paradigm?
Jakob Klemm, Pawel Rajwa, Marcin Miszczyk, Stephan Brönimann, Ekaterina Laukhtina, Ichiro Tsuboi, Akihiro Matsukawa, Mehdi Kardoust Parizi, Pierre I. Karakiewicz, Shahrokh F. Shariat
Genetic testing and management of prostate cancer patients with pathogenic germline variants
Katharina Reiter, Melanie R. Hassler
Renal crystal-storing histiocytosis successfully treated with bortezomib-based regimen
Poornima Tadkal, Siddini Vishwanath, Vankalakunti Mahesha, Kishore Babu, Mallikarjun Kalashetty
Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer
Julia M. Berger, Pia Gattinger, Maximilian J. Mair, Anna S. Berghoff, Rudolf Valenta, Matthias Preusser
Acute myeloid leukemia patient with active disseminated tuberculosis bridged to transplant with reduced 14-day venetoclax and azacitidine schedule
Theresa Lentner, Gerhard Krajnik